Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Gastrodia elata polysaccharide tested in cells, nematodes and aging mice

In this abstract, a Gastrodia elata polysaccharide reduced markers of aging in cells, lengthened nematode lifespan and improved cognition and muscle function in naturally aging mice; gut changes were associated with, not proven to cause, these effects. [1]

Automatic summary · not editorially reviewed

The key findings

  1. GEP was first tested in vitro and in nematodes, then given to naturally aging mice. [1]

  2. In aging mice, GEP ameliorated cognitive impairment, muscle dysfunction and hippocampal neuronal damage. [1]

  3. The gut microbiota link was an association; causal evidence such as fecal transplantation was lacking. [1]

The source at a glance

Study type / format
Preclinical study reported in an abstract
Population / context
BV2 microglia cells, Caenorhabditis elegans nematodes and naturally aging mice.
Summary based on
Study abstract
Original publication
September 30, 2026

GEP tested first in cells and nematodes, then in aging mice

The abstract describes Gastrodia elata polysaccharide (GEP) as a bioactive macromolecule from a food and medicine resource. The authors first checked preliminary anti-aging effects in vitro and in Caenorhabditis elegans, then gave GEP to naturally aging mice. In cells, GEP alleviated senescence of BV2 microglia induced by d-galactose; in nematodes it prolonged lifespan. These are preclinical results, not evidence of human lifespan benefit.

Supporting source [1]

Cognition, muscle and oxidative markers in aging mice

In aging mice, GEP markedly ameliorated cognitive impairment, muscle dysfunction and hippocampal neuronal damage and raised neuroprotective BDNF. It lowered malondialdehyde and increased superoxide dismutase and catalase activity, and activated the Nrf2/Keap1 pathway by downregulating Keap1 and upregulating HO-1 and NQO1. The authors suggest GEP may work by reversing oxidative stress imbalance. It also lowered TNF-α, IL-1β and IL-6 in serum and brain tissue, possibly via inactivation of the TLR4/NF-κB pathway.

Supporting source [1]

Gut microbiota link is association, not proven cause

GEP normalized aging-induced gut dysbiosis, recovered microbial diversity, restored beneficial genera including Akkermansia and Lactobacillus, and elevated intestinal tight junction proteins ZO-1 and occludin. The abstract reports a significant association between this gut microbial remodeling and the neuroprotective phenotypes. The authors state such intestinal improvements may partially contribute through the gut-brain axis, but definitive causal evidence such as fecal microbiota transplantation is lacking in this study.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Results come from cells, nematodes and mice, so they do not show human benefit. The gut-brain link is an association without causal testing.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    further administered GEP to natural aging mice
  2. Finding 2 ↑

    markedly ameliorated cognitive impairment, muscle dysfunction
  3. Finding 3 ↑

    definitive causal evidence such as fecal microbiota

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…